Title:
【発明の名称】イミダゾキノキサリン化合物、その製造及び使用
Document Type and Number:
Japanese Patent JPH05503082
Kind Code:
A
Abstract:
New imidazoquinoxaline compounds having the general formula I (I) wherein wherein R1 and R2 independently are hydrogen, straight or branched C1-6-alkyl, or C3-7-cycloalkyl; R3 is hydrogen, straight or branched C1-6-alkyl, straight or branched C2-6-alkenyl, or aralkyl or aroylalkyl which may optionally be substituted with halogen or C1-6-alkoxy; R4 amd R5 independently are hydrogen, halogen, C1-6-alkyl or trifluoromethyl. The compounds are useful in psychopharmaceutical preparations as anticonvulsants, anxiolytics, hypnotics and in improving the cognitive function of the brain of mammals.
Inventors:
Vetien Frank
Hansen Holgel Klaus
Hansen Holgel Klaus
Application Number:
JP50007291A
Publication Date:
May 27, 1993
Filing Date:
November 22, 1990
Export Citation:
Assignee:
Novo Nordisk Actiesel Scab
International Classes:
A61P25/00; A61P25/08; A61K31/495; A61P25/20; C07D487/04; (IPC1-7): A61K31/495; C07D487/04
Attorney, Agent or Firm:
Minoru Nakamura (6 outside)